1.. Introduction {#S0001}
================

Post-Traumatic Stress Disorder (PTSD) is a debilitating psychiatric disorder with a lifetime prevalence of approximately 8% (Kessler, [2000](#CIT0089)). In addition to the requirement of exposure to a major traumatic event, the diagnostic criteria for PTSD specify the presence of symptoms including re-experiencing the traumatic event; avoiding reminders of the trauma; alterations in arousal and reactivity; and changes in cognition and mood (American Psychiatric Association, [2013](#CIT0005)).

Despite decades of research converging on support for the efficacy of psychological therapy for PTSD (Bisson, Roberts, Andrew, Cooper, & Lewis, [2013](#CIT0012); Bradley, Greene, Russ, Dutra, & Westen, [2005](#CIT0015); Jonas et al., [2013](#CIT0086)), we know remarkably little regarding dropout from these interventions (Foa et al., [2005](#CIT0053); Resick, Nishith, Weaver, Astin, & Feuer, [2002](#CIT0128); Schnurr et al., [2007](#CIT0137); Schottenbauer, Glass, Arnkoff, Tendick, & Gray, [2008](#CIT0141)). Many psychological therapies have been applied to the treatment of PTSD and these have fundamentally different components and proposed active ingredients (Foa, Keane, Friedman, & Cohen, [2008](#CIT0056); Schnyder et al., [2015](#CIT0139)). It follows that these variations may have some influence on differential rates of dropout. Despite this likelihood, there have been few attempts to systematically determine dropout rates from the psychological therapies commonly applied to the treatment of PTSD.

Among the evidence-based therapies for PTSD, a major distinction can be drawn between the therapies that focus on the traumatic event and those that aim to reduce traumatic stress symptoms without directly targeting the trauma memory or related thoughts, with the strongest evidence for the effect of those with a trauma-focus (Bisson et al., [2013](#CIT0012); Bradley et al., [2005](#CIT0015); Jonas et al., [2013](#CIT0086)). Trauma-focused Cognitive Behaviour Therapy (CBT) and Eye Movement Desensitization and Reprocessing (EMDR) are currently recommended as first-line interventions for PTSD (American Psychological Association, [2017](#CIT0006); International Society of Traumatic Stress Studies (ISTSS), [2018](#CIT0079); National Institute for Health and Care Excellence (NICE), [2018](#CIT0114)). These trauma-focused psychological therapies rely on confrontation of traumatic images, which can be difficult to tolerate and may result in the potential for greater dropout (Pitman et al., [1991](#CIT0123); Tarrier et al., [1999a](#CIT0150)). Psychological therapies omitting a role for trauma-focused work may be more tolerable, potentially leading to better retention. However, there is evidence that the absence of a trauma-focus results in poorer outcomes (Bisson et al., [2013](#CIT0012); Bradley et al., [2005](#CIT0015); Jonas et al., [2013](#CIT0086)).

The issue of treatment tolerability and symptom exacerbation resulting from trauma-focused psychological therapies has been one of contention in the literature (Devilly & Foa, [2001](#CIT0036); Hembree et al., [2003](#CIT0068); Tarrier et al., [1999a](#CIT0150)). It is uncertain whether dropout rates vary as a function of treatment modality or whether those with a trauma-focus are associated with poorer retention. To date, a small number of meta-analyses have compared drop-out rates across different modalities of psychological therapy for PTSD (Bradley et al., [2005](#CIT0015); Goetter et al., [2015](#CIT0065); Hembree et al., [2003](#CIT0068), Imel, Laska, Jakupcak, & Simpson, [2013](#CIT0078)). One of these studies reported no differences between therapies with and without exposure-work, however, the review is now dated and includes a far smaller number of studies than currently available (Hembree et al., [2003](#CIT0068)). Another review reported a trend towards greater dropout from exposure-based treatment, but did not analyse this statistically (Bradley et al., [2005](#CIT0015)). A more recent review reported that dropout was not associated with trauma-focus; however, studies comparing trauma-focused CBT to waitlist or usual care control groups were excluded, restricting the review to 42 studies (Imel et al., [2013](#CIT0078)). A more recent review found no difference in dropout rates from therapies that included exposure work in comparison to those that did not, but the review only included twenty studies of US military veterans (Goetter et al., [2015](#CIT0065)).

The aim of the current review was to ascertain rates of dropout across different modalities of psychological therapy and to determine whether some psychological therapies (especially those with a trauma-focus) were associated with higher rates of dropout than others. Since there is no agreed definition of dropout, we took the number of participants that had left the study at the point of post-treatment assessment as a proxy-indicator of dropout in order to allow the inclusion of data from a maximal number of studies. We also aimed to explore potential sources of heterogeneity among the included studies. Our overarching goal was to contribute to a refined understanding of dropout from psychological therapies for PTSD that will inform the development of treatment protocols that maximize retention.

2.. Method {#S0002}
==========

2.1.. Selection criteria {#S0002-S2001}
------------------------

Data on drop-out were extracted from studies that had been identified for a review of the efficacy of psychological therapies for adults with PTSD, which was undertaken as part of an update of the International Society for Traumatic Stress Studies (ISTSS) Treatment Guidelines (International Society of Traumatic Stress Studies (ISTSS), [2018](#CIT0079)). Both reviews had the same inclusion criteria. RCTs of any defined psychological therapy aimed at the reduction of PTSD-symptoms in comparison with a control group (e.g. usual care/waiting list); other psychological therapy; or psychosocial intervention (e.g. psychoeducation/relaxation training) were included. At least 70% of study participants were required to be diagnosed with PTSD with a duration of three months or more, according to DSM or ICD criteria determined by clinician diagnosis or an established diagnostic interview. This review considered studies of adults aged 18 or over, only. There were no restrictions based on symptom-severity or trauma-type. The diagnosis of PTSD was required to be primary and studies of comorbid PTSD and substance use disorder were excluded, but there were no other restrictions based on co-morbidity. Studies were only included if they reported data on the number of participants that had dropped out of the study by the point of post-treatment assessment. If multiple studies reported data on the same participants, dropout data were only included once. We also excluded RCTs of single-session interventions.

2.2.. Search strategy {#S0002-S2002}
---------------------

A search was conducted by the Cochrane Collaboration, which updated a previously published Cochrane review with the same inclusion criteria, which was published in 2013 (Bisson et al., [2013](#CIT0012)). The updated search aimed to identify all RCTs related to the prevention and treatment of PTSD, published from January 2008 to the 31 May 2018, using the search terms PTSD or posttrauma\* or post-trauma\* or 'post trauma\*' or 'combat disorder\*' or 'stress disorder\*'. The searches included results from PubMed, PsycINFO, Embase and the Cochrane database of randomized trials. This produced a group of papers related to the psychological treatment of PTSD in adults. We checked reference lists of the included studies. We searched the World Health Organization's, and the US National Institutes of Health's trials portals to identify additional unpublished or ongoing studies. We contacted experts in the field with the aim of identifying unpublished studies and studies that were in submission. A complementary search of the Published International Literature on Traumatic Stress (PILOTS) was also conducted.

2.3.. Data extraction {#S0002-S2003}
---------------------

Study characteristics and dropout data were extracted by two reviewers independently and in duplicate, using a form that had been pre-piloted. Since there is no agreed definition of dropout, taking the number of participants that had left the study at the point of post-treatment assessment allowed the inclusion of data from a maximal number of studies. Study authors were contacted to obtain missing data. Therapy classifications were agreed with the ISTSS treatment guidelines committee and posted on the ISTSS website to allow comment from the membership. Reasons for dropout and adverse events were not universally available or consistently reported by studies and it was not therefore possible to extract or meta-analyse these data.

2.4.. Risk of bias assessment {#S0002-S2004}
-----------------------------

All included studies were assessed for risk of bias at the study level, using Cochrane criteria (Higgins et al., [2011](#CIT0072)). This included: (1) sequence allocation for randomization (the methods used for randomly assigning participants to the treatment arms and the extent to which this was truly random); (2) allocation concealment (whether or not participants or personnel were able to foresee allocation to a specific group); (3) assessor blinding (whether the assessor was aware of group allocation); (4) incomplete outcome data (whether missing outcome data were handled appropriately); (5) selective outcome reporting (whether reported outcomes matched with those that were pre-specified); and (6) any other notable threats to validity (for example, premature termination of the study). Two researchers independently assessed each study and any conflicts were discussed with a third researcher with the aim of reaching a unanimous decision.

2.5.. Data synthesis {#S0002-S2005}
--------------------

Meta-analyses of proportion were conducted using the *metaprop* command in STATA version 13.1 (StataCorp, [2013](#CIT0146)). The *metaprop* command pools proportions and uses the score statistic and the exact binomial method to compute 95% confidence intervals (Thompson & Higgins, [2002](#CIT0157)). Data were pooled across all active psychological therapies. Sub-group analyses were also conducted to determine the dropout rate for each psychological therapy. A random effects model was chosen due to the heterogeneity across studies in terms of the inclusion and exclusion criteria of the studies; the populations from which the samples were drawn; the nature and duration of therapy; the predominant trauma type; and the mean age of participants.

Heterogeneity was assessed using both the I^2^ statistic (which indicates the proportion of the variance that is due to heterogeneity (Higgins & Green, [2011](#CIT0071))) and visual inspection of the forest plots. To explore potential sources of heterogeneity, meta-regression was performed using the *metareg* function of STATA version 13.1 (StataCorp, [2013](#CIT0146)). Meta-regression assesses the association between study-level variables and the effect size (Thompson & Higgins, [2002](#CIT0157)). It was hypothesized that a number of study-level variables would result in higher rates of drop-out, these being: therapies having a trauma-focus (due to the possibility of these therapies being difficult for some participants to tolerate); therapies being delivered in a group-format (since drop out from group therapies has been found to be greater than from therapies delivered on an individual basis (Imel et al., [2013](#CIT0078))); recruitment from clinical services rather than through advertisements (due to the likelihood of more severe symptoms and a possible tendency for these participants to be less motivated to engage in treatment); whether or not the participants were selected from military/veteran populations (due a greater likelihood of complex or severe PTSD); whether the trauma experienced by participants was sexual (due to the possibility of therapy being more difficult to tolerate); and the percentage of participants who were University educated (due to the possibility that more educated participants are better able to grasp the concepts involved in therapy). To explore the possibility of publication bias, we constructed a funnel plot using data on dropout from all active therapy groups.

3.. Results {#S0003}
===========

The original Cochrane review included 70 RCTs. The update search identified 5500 potentially eligible studies published since 2008. Abstracts were reviewed and full-text copies obtained for 203 potentially relevant studies. Forty-four new RCTs met inclusion criteria for the review and reported data on dropout at the point of post-treatment assessment. This resulted in a total of 115 RCTs of 7724 participants. [Figure 1](#F0001) presents a flow diagram for study selection.10.1080/20008198.2019.1709709-F0001Figure 1.Study flow diagram.10.1080/20008198.2019.1709709-F0002Figure 2.Funnel plot.

3.1.. Study characteristics {#S0003-S2001}
---------------------------

Study characteristics are summarized in [Table 1](#T0001). Twenty-eight defined psychological therapies were evaluated. Eight of these were broadly categorized as CBT with a Trauma Focus (CBT-T) delivered on an individual basis: Brief Eclectic Psychotherapy (BEP); Cognitive Processing Therapy (CPT); Cognitive Therapy (CT); Narrative Exposure Therapy (NET); Prolonged Exposure (PE); Reconsolidation of Traumatic Memories (RTM); Virtual Reality Exposure Therapy (VRE) and CBT-T (not based on a specific model). Thirteen other therapies delivered to individuals were evaluated: EMDR; CBT without a Trauma Focus; Present Centred Therapy (PCT); Supportive Counselling; Written Exposure Therapy; Observed and Experiential Integration (OEI); Interpersonal Psychotherapy; Psychodynamic Psychotherapy; REM Desensitization; Emotional Freedom Technique (EFT); Dialogical Exposure Therapy (DET); Internet-based CBT; and Relaxation Training. There were six different types of group therapy: Group CBT-T; Group Present Centred Therapy (PCT); Group and Individual CBT-T; Group Stabilizing Treatment; Group Interpersonal Therapy; Group Supportive Counselling. There were also RCTs of couples CBT-T. There were six types of control group: psychoeducation; couples psychoeducation; internet-based psychoeducation; waitlist; treatment as usual; and minimal attention/symptom monitoring.10.1080/20008198.2019.1709709-T0001Table 1.Characteristics of included studies.Study*N*CountryIntervention 1Intervention 2Intervention 3Intervention 4PopulationTrauma type% Female% Unemployed% University EducatedAcarturk et al. ([2016](#CIT0001))98Turkey/SyriaEMDRWL  RefugeesWar/Persecution74Unknown4Adenauer et al. ([2011](#CIT0002))34GermanyNET (CBT-T)WL  RefugeesWar/Persecution44UnknownUnknownAhmadi, Hazrati, Ahmadizadeh and Noohi ([2015](#CIT0003))48IranEMDRREM DesensitizationWL Military Personnel/VeteransMilitary Trauma0Unknown33.3Akbarian et al. ([2015](#CIT0004))40IranGroup CBT-TMC/RA  General PopulationVarious79UnknownUnknownAsukai, Saito, Tsuruta, Kishimoto and Nishikawa ([2010](#CIT0007))24JapanPE (CBT-T)TAU  General PopulationVarious88UnknownUnknownBeck, Coffey, Foy, Keane, & Blanchard ([2009](#CIT0008))44USAGroup CBT-TMC/RA  General PopulationRoad Traffic Accident8254UnknownBichescu, Neuner, Schauer and Elbert ([2007](#CIT0011))18RomaniaNET (CBT-T)Psychoeducation  General PopulationPolitical detainment94072Blanchard et al. ([2003](#CIT0013))98USACBT-TSCWL General PopulationRoad Traffic Accident73UnknownUnknownBradshaw, McDonald, Grace, Detwiler and Austin ([2014](#CIT0016))10CanadaOEIWL  General PopulationVarious700UnknownBrom, Kleber and Defares ([1989](#CIT0017))83NetherlandsCBT-TPsychodynamic TherapyWL General PopulationVarious7949UnknownBryant, Moulds, Guthrie, Dang and Nixon ([2003](#CIT0018))58AustraliaCBT-TSC  General PopulationVarious52UnknownUnknown(Bryant et al., [2011](#CIT0019))28ThailandCBT-TSC  General PopulationTerrorism9684%Unknown(Buhmann, Nordentoft, Ekstroem, Carlsson, & Mortensen, [2016](#CIT0022))138DenmarkCBT-TWL  RefugeesOrganized Violence41UnknownUnknown(Butollo, Karl, König, & Rosner, [2016](#CIT0023))148GermanyCPT (CBT-T)DET  General PopulationVarious66UnknownUnknown(Capezzani et al., [2013](#CIT0024))21ItalyEMDRCBT-T  General PopulationMedical Diagnoses/Emergencies90UnknownUnknown(Carletto et al., [2016](#CIT0025))50ItalyEMDRRelaxation Training  General PopulationMedical Diagnoses/Emergencies81UnknownUnknown(Carlson, Chemtob, Rusnak, Hedlund, & Muraoka, [1998](#CIT0026))35USAEMDRRelaxation TrainingTAU Military Personnel/VeteransMilitary Trauma062Unknown(Castillo et al., [2016](#CIT0027))86USAGroup CBT-TWL  Military Personnel/VeteransMilitary Trauma10044Unknown(Chard, [2005](#CIT0028))71USACPT (CBT-T)WL  General PopulationSexual Assault or Rape100UnknownUnknown(Cloitre, Koenen, Cohen, & Han, [2002b](#CIT0032))58USACBT-TWL  General PopulationChild Abuse1002452(Cloitre et al., [2010](#CIT0033))71USACBT-TCBT without a trauma focus  General PopulationChild Abuse10031Unknown**Cooper (1989)**16USAEMDRRelaxation Therapy  Military Personnel/VeteransMilitary Trauma0UnknownUnknown(Devilly, Spence, & Rapee, [1998](#CIT0037))35AustraliaEMDRTAU  Military Personnel/VeteransMilitary Trauma0UnknownUnknown(Devilly & Spence, [1999](#CIT0038))32AustraliaEMDRCBT-T  General PopulationVarious100UnknownUnknown(Dorrepaal et al., [2012](#CIT0041))71NetherlandsGroup Stabilizing TreatmentTAU  General PopulationChild AbuseUnknown83Unknown(Duffy, Gillespie, & Clark, [2007](#CIT0043))58UKCT (CBT-T)WL  General PopulationVarious40UnknownUnknown(Dunne, Kenardy, & Sterling, [2012](#CIT0044))26AustraliaCBT-TWL  General PopulationRoad Traffic Accident503173(Echeburua, Zubizarreta, & Sarasua, [1997](#CIT0045))20SpainCBT-TRelaxation Training  General PopulationSexual Assault or Rape100Unknown20(Ehlers, Clark, Hackmann, McManus, & Fennell, [2005](#CIT0046))28UKCT (CBT-T)WL  General PopulationVarious502535(Ehlers et al., [2003](#CIT0047))57UKCT (CBT-T)MC/RA  General PopulationRoad Traffic AccidentUnknownUnknownUnknown(Ehlers et al., [2014](#CIT0048))91UKCT (CBT-T)SCWL General PopulationVarious582326(Falsetti, Resnick, & Davis, [2008](#CIT0049))60USAGroup CBT-TWL  General PopulationVarious100UnknownUnknown(Fecteau & Nicki, [1999](#CIT0050))20CanadaCBT-TWL  General PopulationRoad Traffic Accident70UnknownUnknown(Feske, [2008](#CIT0051))21USAPE (CBT-T)TAU  General PopulationVarious10029%90%(Foa, Rothbaum, Riggs, & Murdock, [1991](#CIT0055))45USAPE (CBT-T)CBT without a trauma focusSupportive counsellingWLGeneral PopulationSexual Assault or Rape100UnknownUnknown(Foa et al., [1999](#CIT0052))66USAPE (CBT-T)CBT without a trauma focusWL General PopulationSexual Assault or Rape1003841(Foa et al., [2005](#CIT0053))179USAPE (CBT-T)WL  General PopulationAssault1001734(Foa et al., [2018](#CIT0054))256USASpaced PE (CBT-T)PCTMC/RA Military Personnel/VeteransMilitary Trauma1210066(Fonzo et al., [2017](#CIT0058))66USAPE (CBT-T)WL  General PopulationVarious65UnknownUnknown(Forbes et al., [2012](#CIT0059))59AustraliaCPT (CBT-T)TAU  Military Personnel/VeteransMilitary Trauma436Unknown(Ford, Steinberg, & Zhang, [2011](#CIT0061))146USACBT without a trauma focusPCTWL General PopulationVarious100Unknown22(Ford, Chang, Levine, & Zhang, [2013](#CIT0060))80USAGroup CBT-TGroup Supportive Counselling  Incarcerated WomenVarious100UnknownUnknown(Galovski, Blain, Mott, Elwood, & Houle, [2012](#CIT0062))100USACPT (CBT-T)MC/RA  General PopulationVarious69UnknownUnknown(Gamito et al., [2010](#CIT0063))10PortugalVRE (CBT-T)Control ExposureWL Military Personnel/VeteransMilitary Trauma0UnknownUnknown(Gersons, Carlier, Lamberts, & Van der Kolk, [2000](#CIT0064))42NetherlandsBEP (CBT-T)WL  General PopulationVariousUnknownUnknownUnknown(Gray, Budden-Potts, & Bourke, [2017](#CIT0066))74USARTM (CBT-T)WL  Military Personnel/VeteransMilitary Trauma0UnknownUnknown(Hensel-Dittmann et al., [2011](#CIT0069))28GermanyNET (CBT-T)CBT without a trauma focus  Asylum SeekersOrganized ViolenceUnknownUnknownUnknown(Hinton et al., [2005](#CIT0073))40USACBT-TWL  RefugeesGenocide60UnknownUnknown(Hinton, Hofmann, Rivera, Otto, & Pollack, [2011](#CIT0074))24USAGroup CBT-TWL  General PopulationVarious100UnknownUnknown(Hogberg et al., [2007](#CIT0075))24SwedenEMDRWL  General PopulationVarious38UnknownUnknown(Hollifield, Sinclair-Lian, Warner, & Hammerschlag, [2007](#CIT0076))55USAGroup trauma-focused CBTWL  General PopulationVarious68Unknown40(Ironson, Freund, Strauss, & Williams, [2002](#CIT0080))22USAEMDRPE (CBT-T)  General PopulationVarious77UnknownUnknown(Ivarsson et al., [2014](#CIT0081))62SwedenI-CBTWL  General PopulationVarious82865(Jacob, Neuner, Maedl, Schaal, & Elbert, [2014](#CIT0082))76RwandaNET (CBT-T)WL  Genocide SurvivorsGenocide92UnknownUnknown(Jensen, [1994](#CIT0083))25USAEMDRWL  Military Personnel/VeteransMilitary Trauma068Unknown(Johnson, Zlotnick, & Perez, [2011](#CIT0085))70USACBT without a trauma focusTAU  General PopulationDomestic Abuse100737(Johnson, Johnson, Perez, Palmieri, & Zlotnick, [2016](#CIT0084))60USACBT without a trauma focusTAU  General PopulationDomestic Abuse100775(Karatzias et al., [2011](#CIT0087))46UKEMDREFT  General PopulationVarious573747(Keane, Fairbank, Caddell, & Zimering, [1989](#CIT0088))24USACBT-TWL  Military Personnel/VeteransMilitary Trauma0UnknownUnknown(Krupnick et al., [2008](#CIT0091))48USAGroup IPTWL  General PopulationVarious1008013%(Kubany, Hill, & Owens, [2003](#CIT0093))37USACBT-TWL  General PopulationDomestic Abuse100UnknownUnknown(Kubany, Hill, & Owens, [2004](#CIT0092))107USACBT-TWL  General PopulationDomestic Abuse100UnknownUnknown(Laugharne et al., [2016](#CIT0095))20AustraliaEMDRPE (CBT-T)  General PopulationVarious70UnknownUnknown(Lee, Gavriel, Drummond, Richards, & Greenwald, [2002](#CIT0096))24AustraliaCBT-TEMDR  General PopulationVarious46UnknownUnknown(Lewis et al., [2017](#CIT0098))42UKI-CBTWL  General PopulationVarious571962**Lindauer**24NetherlandsBEPWL  General PopulationVarious54UnknownUnknown**Littleton (2016) (**Littleton, Grills, Kline, Schoemann, & Dodd, [2016](#CIT0101))87USAI-CBTI-Psychoeducation  General PopulationSexual Assault or Rape100UnknownUnknown(Litz, Engel, Bryant, & Papa, [2007](#CIT0102))45USAI-CBTI-SC  Military Personnel/VeteransTerrorism/Military TraumaUnknownUnknownUnknown(Marcus, Marquis, & Sakai, [1997](#CIT0103))67USAEMDRTAU  General PopulationVarious79UnknownUnknown(Markowitz et al., [2015](#CIT0104))110USAIPTPE (CBT-T)Relaxation Therapy General PopulationVarious7021Unknown(Marks, Lovell, Noshirvani, Livanou, & Thrasher, [1998](#CIT0105))87UKPE (CBT-T)Cognitive RestructuringPE (CBT-T) (CBT-T)(CBT-T)and Cognitive RestructuringRelaxation without PE (CBT-T) (CBT-T)(CBT-T)or CRGeneral PopulationVarious3654Unknown(McDonagh et al., [2005](#CIT0106))74USAPE (CBT-T)PCTWL General PopulationSexual Assault or Rape10017Unknown(McLay et al., [2011](#CIT0108))20USAVRE (CBT-T)TAU  Military Personnel/VeteransMilitary Trauma5UnknownUnknown(McLay et al., [2017](#CIT0107))81USAVRE (CBT-T)Control Exposure Therapy  Military Personnel/VeteransMilitary Trauma4UnclearUnclear(Monson et al., [2012](#CIT0109))20USACouples CBT-TWL  General PopulationVarious2540Unknown(Monson et al., [2006](#CIT0110))60USACPT (CBT-T)WL  Military Personnel/VeteransMilitary Trauma10UnknownUnknown(Morath et al., [2014](#CIT0111))38GermanyNET (CBT-T)WL  RefugeesOrganized Violoence32UnknownUnknown(Mueser et al., [2008](#CIT0112))108USACBT-TTAU  General PopulationVarious79UnknownUnknown(Nacasch et al., [2011](#CIT0113))30IsraelPE (CBT-T)TAU  Military Personnel/VeteransMilitary TraumaUnknown63Unknown(Neuner et al., [2010](#CIT0115))32GermanyNET (CBT-T)TAU  RefugeesTorture31UnknownUnknown(Neuner et al., [2008](#CIT0116))277UgandaNET (CBT-T)SCMonitoring RefugeesWar/Persecution5149Unknown(Neuner, Schauer, Klaschik, Karunakara, & Elbert, [2004](#CIT0117))43UgandaNET (CBT-T)SCPsychoeducation RefugeesWar/Persecution6028Unknown(Nijdam, Gersons, Reitsma, de Jongh, & Olff, [2012](#CIT0118))140NetherlandsBEP (CBT-T)EMDR  General PopulationVarious56Unknown30(Pacella et al., [2012](#CIT0120))66USAPE (CBT-T) (CBT-T)MC/RA  General PopulationMedical Diagnoses/Emergencies37UnknownUnknown(Paunovic, [2011](#CIT0121))29SwedenCBT-TWL  General PopulationVarious637411(Peniston & Kulkosky, [1991](#CIT0122))29USACBT-TTAU  Military Personnel/VeteransMilitary TraumaUnknownUnknownUnknown(Power et al., [2002](#CIT0124))105UKEMDRCBT-TWL General PopulationVarious42UnknownUnknown(Rauch et al., [2015](#CIT0125))36USAPE (CBT-T) (CBT-T)PCT  Military Personnel/VeteransMilitary Trauma9UnknownUnknown(Ready, Gerardi, Backscheider, Mascaro, & Rothbaum, [2010](#CIT0126))11USAVRE (CBT-T)PCT  Military Personnel/VeteransMilitary TraumaUnknownUnknownUnknown(Reger et al., [2016](#CIT0127))162USAVRE (CBT-T)PE (CBT-T)WL Military Personnel/VeteransMilitary Trauma4Active duty7(Resick et al., [2015](#CIT0130))108USAGroup CBT-TGroup PCT  Military Personnel/VeteransMilitary Trauma808(Resick et al., [2002](#CIT0128))171USACPT (CBT-T) (CBT-T)PE (CBT-T)Minimal Attention General PopulationSexual Assault or Rape100UnknownUnknown(Resick et al., [2017](#CIT0129))268USACPT (CBT-T) (CBT-T)Group CBT-T  Military Personnel/VeteransMilitary Trauma910019(Rothbaum, [1997](#CIT0132))18USAEMDRWL  General PopulationSexual Assault or Rape1001943(Rothbaum, Astin, & Marsteller, [2005](#CIT0133))60USAPE (CBT-T)EMDRWL General PopulationSexual Assault or Rape100UnknownUnknown(Sautter, Glynn, Cretu, Senturk, & Vaught, [2015](#CIT0135))57USACouples CBT without a trauma focusCouples Psychoeducation  Military Personnel/VeteransMilitary Trauma1.751275(Scheck, Schaeffer, & Gillette, [1998](#CIT0136))60USAEMDRSC  General PopulationVarious100UnknownUnknown(Schnurr et al., [2003](#CIT0138))360USAGroup CBT-TGroup PCT  Military Personnel/VeteransMilitary Trauma051Unknown(Schnurr et al., [2007](#CIT0137))284USAPE (CBT-T) (CBT-T)Group PCT  Military Personnel/VeteransMilitary Trauma10038Unknown(Schnyder, Müller, Maercker, & Wittmann, [2011](#CIT0140))30SwitzerlandBEP (CBT-T)MC/RA  General PopulationVarious46.7UnknownUnknown**Shemesh**60USACBT-TPsychoeducation  General PopulationMedical Diagnoses/Emergencies33UnknownUnknown(Sloan, Marx, Bovin, Feinstein, & Gallagher, [2012](#CIT0143))46USAWETWL  General PopulationRoad Traffic AccidentUnclear7841(Sloan, Marx, Lee, & Resick, [2018](#CIT0144))126USAWETCPT (CBT-T)  General PopulationVarious49Unknown13(Spence et al., [2011](#CIT0145))42AustraliaI-CBTWL  General PopulationVarious8141Not clear(Stenmark, Catani, Neuner, Elbert, & Holen, [2013](#CIT0147))81NorwayNET (CBT-T)TAU  RefugeesVarious31Unknown25(Suris, Link-Malcolm, Chard, Ahn, & North, [2013](#CIT0148))86USACPT (CBT-T)PCT  Military Personnel/VeteransSexual Assault or Rape854316(Taylor et al., [2003](#CIT0154))60USAPE (CBT-T)Relaxation TherapyEMDR General PopulationVarious7513Unknown(Tylee, Gray, Glatt, & Bourke, [2017](#CIT0158))30USARTM (CBT-T)WL  General PopulationMilitary Trauma0UnknownUnknown(Vaughan et al., [1994](#CIT0160))36AustraliaCBT-TRelaxation TrainingEMDR General PopulationVarious64UnknownUnknown(Wells et al., [2015](#CIT0163))32UKPE (CBT-T)CBT without a trauma focusWL General PopulationVarious386Unknown(Wells & Sembi, [2012](#CIT0162))20UKCBT without a trauma focusWL  General PopulationVarious55UnknownUnknown(Yehuda et al., [2014](#CIT0164))52USAPE (CBT-T)MC/RA  Military Personnel/VeteransMilitary TraumaUnclearUnknownUnknown(Zang, Hunt, & Cox, [2014](#CIT0167))20ChinaNET (CBT-T)WL  General PopulationEarthquake90UnknownUnknown(Zang, Hunt, & Cox, [2013](#CIT0166))22ChinaNET (CBT-T)WL  General PopulationEarthquake77UnknownUnknown(Zlotnick et al., [1997](#CIT0169))48USAGroup CBT-TWL  General PopulationSexual Assault or Rape100Unknown33[^2][^3][^4][^5][^6][^7][^8][^9][^10][^11][^12][^13][^14][^15]

The number of randomized participants ranged from 10 to 360. Studies were conducted in Australia (9), Canada (2), China (2), Denmark (1), Germany (5), Iran (2), Israel (1), Italy (2), Japan (1), the Netherlands (5), Norway (1), Portugal (1), Romania (1), Rwanda (1), Spain (1), Sweden (3), Switzerland (1), Thailand (1), Turkey/Syria (1), Uganda (2), UK (10) and USA (62). Participants were traumatized by military trauma (27 studies), sexual assault or rape (11 studies), war/persecution (4 studies), road traffic accidents (6 studies), earthquakes (2 studies), childhood abuse (3 studies), political detainment (1 study), terrorism (2 studies), physical assault (2 studies), domestic abuse (4 studies), medical diagnoses/emergencies (4 studies), genocide (1 study) and organized violence (3 studies). The remainder included individuals traumatized by various different traumatic events. There were 27 studies of females only and 10 of only males; the percentage of females in the remaining studies ranged from 1.75% to 96%. The percentage with a University education ranged from 4% to 90%.

3.2.. Risk of bias {#S0003-S2002}
------------------

Risk of bias assessments for the included studies are summarized in [Table 2](#T0002). Fifty-two studies reported a method of sequence allocation judged to pose a 'low' risk of bias; five reported a method with a 'high' risk of bias; the remainder reported insufficient details and were, therefore, rated as 'unclear'. Forty-one studies reported methods of allocation concealment representing a 'low' risk of bias; two a method with a 'high' risk of bias; with the remainder rated as 'unclear'. The outcome assessor was aware of the participant's allocation in 11 of the included studies; it was unclear whether the outcome assessor was aware of group allocation in 20 studies; with the remainder using blind-raters or self-report questionnaires delivered in a way that could not be influenced by members of the research team. Twenty-three studies were judged as posing a 'high' risk of bias in terms of incomplete outcome data; 79 studies were felt to have dealt with dropouts appropriately ('low' risk of bias); it was unclear in the remaining studies. The majority of studies failed to reference a published protocol, resulting in an 'unclear' risk of selective reporting for 75 studies; risk of bias was judged as 'high' in five studies and low in the remainder. Seventy of the included studies presented a 'high' risk of bias in other areas, for example, in relation to sample size, baseline imbalances between groups, or other methodological shortfalls. We could not rule out potential researcher allegiance, since treatment originators were involved in the evaluation of their own intervention in many of the included studies.10.1080/20008198.2019.1709709-T0002Table 2.Risk of bias assessments of the included studies. Random sequence generationAllocation concealmentIncomplete outcome data assessmentBlinding of outcomeSelective reportingOther sources of biasTotal no. high risk(Acarturk et al., [2016](#CIT0001))LowLowLowLowLowLow0(Adenauer et al., [2011](#CIT0002))LowLowLowLowHighHigh2(Ahmadi et al., [2015](#CIT0003))UnclearUnclearHighUnclearUnclearHigh2(Akbarian et al., [2015](#CIT0004))LowHighLowLowUnclearHigh2(Asukai et al., [2010](#CIT0007))LowLowLowLowUnclearHigh1(Beck et al., [2009](#CIT0008))UnclearUnclearHighLowUnclearHigh2(Bichescu et al., [2007](#CIT0011))HighUnclearLowLowUnclearHigh2(Blanchard et al., [2003](#CIT0013))HighUnclearLowLowUnclearLow1(Bradshaw et al., [2014](#CIT0016))UnclearUnclearLowHighUnclearHigh2(Brom et al., [1989](#CIT0017))UnclearUnclearHighUnclearUnclearHigh2(Bryant et al., [2003](#CIT0018))LowUnclearLowLowLowHigh1(Bryant et al., [2011](#CIT0019))LowLowLowLowUnclearHigh1(Buhmann et al., [2016](#CIT0022))LowLowUnclearLowLowLow0(Butollo et al., [2016](#CIT0023))UnclearUnclearLowLowUnclearHigh1(Capezzani et al., [2013](#CIT0024))UnclearUnclearLowLowUnclearHigh1(Carletto et al., [2016](#CIT0025))LowLowHighLowLowLow1(Carlson et al., [1998](#CIT0026))UnclearUnclearHighUnclearUnclearLow1(Castillo et al., [2016](#CIT0027))UnclearUnclearLowLowUnclearHigh1(Chard, [2005](#CIT0028))UnclearUnclearLowLowUnclearHigh1(Cloitre et al., [2002b](#CIT0032))UnclearUnclearLowLowHighLow1(Cloitre et al., [2010](#CIT0033))UnclearLowLowLowLowLow0(Cooper & Conklin, [2015](#CIT0034))HighHighHighUnclearLowHigh4(Devilly et al., [1998](#CIT0037))UnclearUnclearHighLowUnclearLow1(Devilly & Spence, [1999](#CIT0038))HighUnclearHighUnclearUnclearHigh3(Dorrepaal et al., [2012](#CIT0041))UnclearLowLowLowHighHigh2(Duffy et al., [2007](#CIT0043))LowLowLowUnclearLowHigh1(Dunne et al., [2012](#CIT0044))UnclearUnclearLowUnclearUnclearHigh1(Echeburua et al., [1997](#CIT0045))UnclearUnclearLowUnclearUnclearHigh1(Ehlers et al., [2003](#CIT0047))LowLowHighLowUnclearHigh2(Ehlers et al., [2005](#CIT0046))UnclearUnclearLowLowUnclearHigh2(Ehlers et al., [2014](#CIT0048))UnclearLowLowLowLowLow0(Falsetti et al., [2008](#CIT0049))UnclearUnclearLowLowHighHigh2(Fecteau & Nicki, [1999](#CIT0050))LowUnclearHighUnclearUnclearHigh2(Feske, [2008](#CIT0051))UnclearUnclearLowUnclearUnclearHigh1(Foa et al., [1991](#CIT0055))UnclearUnclearHighLowUnclearHigh2(Foa et al., [1999](#CIT0052))UnclearUnclearLowLowUnclearHigh1(Foa et al., [2005](#CIT0053))LowLowLowLowUnclearLow0(Foa et al., [2018](#CIT0054))LowLowLowLowLowLow0(Fonzo et al., [2017](#CIT0058))LowUnclearLowUnclearLowLow0(Forbes et al., [2012](#CIT0059))UnclearLowLowUnclearUnclearHigh1(Ford et al., [2011](#CIT0061))LowLowLowLowUnclearHigh1(Ford et al., [2013](#CIT0060))LowLowHighLowUnclearHigh2(Galovski et al., [2012](#CIT0062))UnclearUnclearLowLowUnclearLow0(Gamito et al., [2010](#CIT0063))UnclearUnclearUnclearUnclearHighHigh2(Gersons et al., [2000](#CIT0064))UnclearUnclearLowLowUnclearLow0(Gray et al., [2017](#CIT0066))LowLowUnclearUnclearUnclearUnclear0(Hensel-Dittmann et al., [2011](#CIT0069))LowLowLowLowUnclearLow0(Hinton et al., [2005](#CIT0073))LowUnclearLowLowUnclearHigh1(Hinton et al., [2011](#CIT0074))UnclearUnclearLowUnclearUnclearHigh1(Hogberg et al., [2007](#CIT0075))LowUnclearHighLowUnclearHigh2(Hollifield et al., [2007](#CIT0076))LowLowLowLowUnclearHigh1(Ironson et al., [2002](#CIT0080))UnclearUnclearLowHighUnclearHigh2(Ivarsson et al., [2014](#CIT0081))LowUnclearLowLowLowHigh1(Jacob et al., [2014](#CIT0082))LowLowLowLowUnclearHigh1(Jensen, [1994](#CIT0083))UnclearUnclearHighUnclearUnclearHigh2(Johnson et al., [2011](#CIT0085))LowUnclearLowHighUnclearLow1(Johnson et al., [2016](#CIT0084))LowLowLowLowUnclearLow0(Karatzias et al., [2011](#CIT0087))LowLowLowLowUnclearHigh1(Keane et al., [1989](#CIT0088))UnclearUnclearUnclearHighUnclearHigh2(Krupnick et al., [2008](#CIT0091))UnclearUnclearLowUnclearUnclearHigh1(Kubany et al., [2003](#CIT0093))UnclearUnclearLowLowUnclearHigh1(Kubany et al., [2004](#CIT0092))UnclearUnclearLowLowLowHigh1(Laugharne et al., [2016](#CIT0095))LowLowLowLowUnclearHigh1(Lee et al., [2002](#CIT0096))UnclearUnclearLowLowUnclearHigh1(Lewis et al., [2017](#CIT0098))LowLowLowLowLowHigh1(Lindauer et al., [2005](#CIT0099))LowLowLowLowLowHigh (Littleton et al., [2016](#CIT0101))LowUnclearLowHighLowLow1(Litz et al., [2007](#CIT0102))UnclearUnclearHighLowLowHigh2(Marcus et al., [1997](#CIT0103))UnclearUnclearUnclearHighUnclearHigh2(Markowitz et al., [2015](#CIT0104))LowLowLowLowLowHigh1(Marks et al., [1998](#CIT0105))UnclearUnclearLowLowUnclearLow0(McDonagh et al., [2005](#CIT0106))UnclearUnclearLowLowUnclearLow0(McLay et al., [2011](#CIT0108))LowLowUnclearHighUnclearHigh2(McLay et al., [2017](#CIT0107))LowUnclearLowLowLowLow0(Monson et al., [2012](#CIT0109))LowLowLowLowLowLow0(Monson et al., [2006](#CIT0110))LowLowLowLowUnclearLow0(Morath et al., [2014](#CIT0111))LowLowUnclearLowLowLow0(Mueser et al., [2008](#CIT0112))LowLowLowLowUnclearHigh1(Nacasch et al., [2011](#CIT0113))LowUnclearLowLowLowHigh1(Neuner et al., [2004](#CIT0117))LowUnclearLowLowLowHigh1(Neuner et al., [2008](#CIT0116))UnclearUnclearLowLowUnclearLow0(Neuner et al., [2010](#CIT0115))UnclearUnclearLowLowUnclearHigh1(Nijdam et al., [2012](#CIT0118))UnclearLowLowLowLowLow0(Pacella et al., [2012](#CIT0120))LowUnclearLowLowUnclearLow0(Paunovic, [2011](#CIT0121))UnclearUnclearLowHighUnclearHigh2(Power et al., [2002](#CIT0124))LowLowHighLowUnclearLow1(Rauch et al., [2015](#CIT0125))UnclearUnclearLowLowUnclearHigh1(Ready et al., [2010](#CIT0126))UnclearUnclearUnclearLowUnclearHigh1(Reger et al., [2016](#CIT0127))LowLowLowLowUnclearLow0(Resick et al., [2002](#CIT0128))UnclearUnclearLowLowUnclearHigh1(Resick et al., [2015](#CIT0130))UnclearUnclearLowLowUnclearLow0(Resick et al., [2017](#CIT0129))LowUnclearLowLowLowLow0(Rothbaum, [1997](#CIT0132))UnclearUnclearHighLowUnclearHigh2(Rothbaum et al., [2005](#CIT0133))UnclearUnclearHighLowUnclearLow1(Sautter et al., [2015](#CIT0135))UnclearUnclearLowLowUnclearLow0(Scheck et al., [1998](#CIT0136))LowLowHighUnclearUnclearHigh2(Schnurr et al., [2003](#CIT0138))HighUnclearLowLowLowLow1(Schnurr et al., [2007](#CIT0137))LowLowLowLowLowLow0**Shemesh**LowLowUnclearUnclearUnclearLow0(Sloan et al., [2012](#CIT0143))LowLowUnclearLowUnclearLow0(Sloan et al., [2018](#CIT0144))LowLowLowLowLowLow0(Spence et al., [2011](#CIT0145))LowUnclearHighHighLowUnclear2(Stenmark et al., [2013](#CIT0147))UnclearUnclearLowHighLowHigh2(Suris et al., [2013](#CIT0148))UnclearUnclearLowLowLowHigh1(Taylor et al., [2003](#CIT0154))UnclearUnclearLowLowUnclearLow0(Tylee et al., [2017](#CIT0158))UnclearUnclearUnclearLowUnclearHigh1(Vaughan et al., [1994](#CIT0160))UnclearUnclearLowLowUnclearLow0(Wells & Sembi, [2012](#CIT0162))LowLowLowLowUnclearHigh1(Wells et al., [2015](#CIT0163))LowLowHighHighUnclearHigh3(Yehuda et al., [2014](#CIT0164))UnclearUnclearHighUnclearUnclearUnclear1(Zang et al., [2013](#CIT0166))UnclearUnclearLowLowLowHigh1(Zang et al., [2014](#CIT0167))LowUnclearLowLowLowHigh1(Zlotnick et al., [1997](#CIT0169))UnclearUnclearHighLowLowHigh2

3.3.. Dropout {#S0003-S2003}
-------------

Across the different modalities of psychological therapy, dropout rates from individual studies ranged from 0%-65%. The pooled dropout rate from psychological therapies for PTSD was 16% (95% CI 14--18; k = 116) with substantial heterogeneity across studies (I^2^ = 77.3%). The dropout rate for each modality of psychological therapy is presented in [Table 3](#T0003). The heterogeneity in dropout rates indicates differences that may be predicted by the variables entered into meta-regression.10.1080/20008198.2019.1709709-T0003Table 3.Results of the meta-analyses of dropout. Number of studiesMean % drop out (95% CI)I^2^ (%)1. CBT-T (not based on a specific model)2513 (9--18)64.412. Brief Eclectic Psychotherapy317 (0--51)90.403. Cognitive Processing Therapy (CPT)830 (22--39)75.154. Cognitive Therapy (CT)69 (1--23)82.725. Narrative Exposure Therapy1112 (3--26)85.596. Prolonged Exposure (PE)2222 (16--28)72.567. Reconsolidation of Traumatic Memories (RTM)11 (0--8)0.008. Virtual Reality Exposure (VRE)518 (3--38)76.329. Eye Movement Desensitization and Reprocessing (EMDR)2118 (12--24)62.1310. CBT without a trauma focus914 (7--23)61.9611. Present Centred Therapy (PCT)620 (13--28)40.8512. Supportive Counselling915 (3--32)87.8413. Observed and Experiential Integration (OEI)10Not applicable14. Interpersonal Psychotherapy (IPT)115 (6--30)Not applicable15. Psychodynamic Psychotherapy114Not applicable16. REM Desensitization138Not applicable17. Emotional Freedom Technique (EFT)139Not applicable18. Dialogical Exposure Therapy (DET)112Not applicable19. Internet-based CBT316 (8--26)32.1220. Relaxation Training810 (3--19)56.8021. Group CBT with a Trauma Focus (group CBT-T)924 (16--33)76.2922. Group Present Centred Therapy (PCT)314 (11--18)0.0023. Group and Individual CBT-T122Not applicable24. Group Stabilizing Treatment118Not applicable25. Group Interpersonal Psychotherapy138Not applicable26. Group Supportive Counselling13Not applicable27. Couples CBT-T222 (11--36)0.0028. Psychoeducation31 (0--7)0.0029. Couples Psychoeducation312 (3--25)64.0030. Internet-based psychoeducation17Not applicable31. Waitlist5311 (8--15)65.4332. Treatment usual1413 (7--19)61.3733. Minimal attention/symptom monitoring813 (2--32)92.30 10.1080/20008198.2019.1709709-T0004Table 4.Meta-regression of study-level variables on dropout from all active psychological therapies.Variable*β* (95% confidence intervals)*P*Trauma focus0.069 (0.011--0.127)0.021Recruitment from clinical services−0.028 (−0.087--0.030)0.341Delivered in a group format−0.022 (−0.096--0.523)0.564Sample drawn from military population0.032 (−0.023--0.087)0.251Sexual trauma0.040 (−0.049--0.130)0.376% Female0.040 (−0.049--0.130)0.376% University educated0.001 (−0.003--0.001)0.208[^16]

3.4.. Meta-regression {#S0003-S2004}
---------------------

Results of the meta-regressions are presented in [Table 4](#T0004). We found evidence that psychological therapies with a trauma-focus were significantly associated with greater dropout (β = 0.069; CI 0.011--0.127; P = 0.021; dropout rate of 18% (95% CI 15--21%) from those with a trauma focus versus 14% (95% CI 10--18%) from those without a trauma focus). There was no evidence of greater dropout from therapies delivered in a group format; from studies that recruited participants from clinical services rather than via advertisements; that included only military personnel/veterans; that included only participants traumatized by sexual traumas; from studies with a higher proportion of female participants; or from studies with a lower proportion of participants who were University educated.

3.5.. Publication bias {#S0003-S2005}
----------------------

A funnel plot (see [Figure 2](#F0002)), which was constructed using data on dropout from all active therapy groups, did not show evidence of publication bias.

4.. Discussion {#S0004}
==============

4.1.. Main findings {#S0004-S2001}
-------------------

Taking the number of participants that had left the study at the point of post-treatment assessment as a proxy-indicator of dropout, the pooled rate from psychological therapies for PTSD was 16% (95% CI 14--18%). This is of a similar magnitude to a previous meta-analysis of 42 studies, which found an average dropout rate of 18% (Imel et al., [2013](#CIT0078)) using the definition of dropout given by the included studies. This is also similar to the dropout rate of 17.5% obtained from a meta-analysis of dropout from RCTs of psychotherapy for depression (Cooper & Conklin, [2015](#CIT0034)) that defined dropout as unexpected attrition among individuals who were randomized to a treatment but failed to complete it. It was considerably lower than the pooled drop-out rate of 36% found by a more recent review of twenty studies of US military veterans (Goetter et al., [2015](#CIT0065)). This was in comparison to a pooled dropout rate from studies of veterans/military personnel in this review of 18% (95% CI 15--22%). This is likely to reflect the fact that the previous review included a variety of different study designs including naturalistic studies and used the definition of dropout given by the authors of individual studies.

There was no evidence of greater dropout from therapies delivered in a group format. This contradicts the findings of earlier reviews that found group delivery to be associated with a significant increase in dropout (Goetter et al., [2015](#CIT0065); Imel et al., [2013](#CIT0078)). This may be the result of more recent studies evaluating interventions that have been optimized to increase retention or more proactive attempts to retain participants. There was also no evidence of significantly greater dropout from studies that recruited participants from clinical services rather than via advertisements; that included only military personnel/veterans; that included only participants traumatized by sexual traumas; that included only female participants; and from studies with a lower proportion of participants who were University educated. Research looking at factors associated with dropout have yielded inconsistent findings (Bryant et al., [2007](#CIT0021); Schottenbauer et al., [2008](#CIT0141); Taylor, [2003](#CIT0153)). Although the findings of the current review contradict some previous studies; they are in agreement with others. Inconsistencies may be the result of difference in study type and design; the types of interventions of interest and the degree to which they are protocolized; or may vary according to the populations of interest.

We found evidence that psychological therapies with a trauma-focus were significantly associated with greater dropout. This challenges the findings of previous, far smaller, meta-analyses, which found no significant differences in dropout rates from therapies with and without a trauma-focus (Goetter et al., [2015](#CIT0065); Hembree et al., [2003](#CIT0068)). However, one of these studies found a significant difference between PCT (a non-trauma-focused intervention) and a group of therapies that had a trauma-focus (Imel et al., [2013](#CIT0078)). Our findings may be a result of the accumulated data available from a larger number of studies. The results, however, are consistent with the findings of a review of seven studies of treatments specifically targeting child abuse-related or complex PTSD, which found some evidence of greater drop-out from exposure-based therapies (Dorrepaal et al., [2014](#CIT0040)). Although there are many reasons for dropout from psychological therapies, this finding suggests that difficulties tolerating trauma-focused treatment may be one of these. Adverse events such as the prolonged exacerbation of existing symptoms (for example, an increased frequency of unwanted thoughts or nightmares) or the occurrence of new symptoms (for example, anger or self-blame) may lead to dropout, yet there is a surprising scarcity of research exploring the issue (Berk & Parker, [2009](#CIT0010)). Psychological therapy is traditionally perceived as safe, presenting a low risk of unwanted effects (Nutt & Sharpe, [2008](#CIT0119)). In reality, the estimated rate of reported side effects is between 3% and 15%, which is of a similar magnitude to that reported for pharmacotherapy (Linden, [2012](#CIT0100)). However, it is often difficult to draw a distinction between adverse events and time-limited negative experiences inherent to the process of some psychological therapies. This includes the experience of distress provocation, which is inevitable in the process of trauma-focused work.

A survey of psychologists' attitudes to trauma-focused intervention found that concerns about tolerability and dropout were among the main reasons that psychologists did not use trauma-focused intervention, despite the compelling evidence supporting its use (Becker, Zayfert, & Anderson, [2004](#CIT0009)). However, only a small number of studies have acknowledged or explored adverse events such as symptom worsening or its influence on dropout in relation to trauma-focused therapy. This is surprising, given that symptom exacerbation has long since been documented in the treatment of PTSD (Pitman et al., [1991](#CIT0123); Tarrier et al., [1999b](#CIT0151)). It also limits our ability to judge how well various therapies were tolerated by PTSD sufferers. An RCT of imagery rehearsal therapy for trauma-related nightmares found that all four participants who actively withdrew from the treatment group had experienced increased negative imagery effects, suggesting a direct relationship between an inability to tolerate the treatment and subsequent dropout (Krakow et al., [2001](#CIT0090); Tarrier, Sommerfield, Pilgrim, & Humphreys, [1999](#CIT0152)). Conversely, a study of 76 individuals found that only 9--21% of participants showed reliable symptom exacerbation, and these individuals were no more likely to drop out of treatment prematurely (Foa, Zoellner, Hembree, & Alvarez-Conrad, [2002](#CIT0057)). Similarly, an RCT comparing cognitive therapy (without a trauma focus) to imaginal exposure found that symptom worsening affected 10% of participants, with a significantly greater number of these being in the imaginal exposure group; however, this between-group difference was no longer present at follow-up and rates of dropout were similar from both groups (Tarrier et al., [1999](#CIT0152)).

The studies included in this review usually failed to provide information on adverse events and contained few explanations for dropout, so it is difficult to ascertain the reasons that participants dropped out. It must be acknowledged that symptom improvement is a possible reason for dropout (Szafranski, Smith, Gros, & Resick, [2017](#CIT0149)). It follows that termination of treatment for this reason would be highest from the most effective treatments (i.e. those with a trauma-focus (Bisson et al., [2013](#CIT0012); Bradley et al., [2005](#CIT0015); Jonas et al., [2013](#CIT0086))). This said, recent studies have found that those who attend more treatment sessions generally obtain more favourable outcomes (Holmes et al., [2019](#CIT0077); Rutt, Oehlert, Krieshok, & Lichtenberg, [2018](#CIT0134)). More transparent reporting of dropout is required to explore this further. Whatever the cause, dropout is a major health and societal concern, which may result in individuals failing to receive optimal treatment (Craske et al., [2006](#CIT0035)).

4.2.. Strengths and limitations {#S0004-S2002}
-------------------------------

The review followed Cochrane guidelines for the identification of relevant studies; data extraction; and risk assessment (Higgins & Green, [2011](#CIT0071)). A wide range of psychological therapies for PTSD were considered, which included participants from different countries and backgrounds, who had been exposed to a variety of different traumatic events. Inevitably, there were some limitations. The majority of studies included in the review excluded individuals with comorbidities of substance dependence, psychosis, and severe depression, who may be more likely to drop out of treatment prematurely, as evidenced by particularly high rates of drop out from studies of participants with co-morbid alcohol dependency (Bothwell, Greene, Podolsky, & Jones, [2016](#CIT0014); Roberts, Jones, & Bisson, [2016](#CIT0131); Zandberg et al., [2016](#CIT0165)). All included studies were published, resulting in the possibility of publication bias. However, a funnel plot constructed from the data did not show evidence of this being an issue.

Since there is no agreed conceptualization of dropout, this review extracted and meta-analysed data on the number of participants that had left the study at the point of post-treatment assessment to allow the inclusion of data from a maximal number of studies. There may have been some participants who completed a full course of therapy but failed to attend the post-treatment assessment. Equally, there may have been some participants who failed to complete the course of treatment but attended the post-treatment assessment nonetheless. Although this may bias our findings, there are limitations to all methods that we could have adopted to conceptualize dropout.

The review relied on RCT evidence, which is both a strength and a limitation. The methodology may have excluded some potentially high-quality sources of evidence, such as large observational studies and non-randomized controlled effectiveness studies (Bothwell et al., [2016](#CIT0014)), which could contribute to a more accurate overall assessment of dropout. It may be the case that dropout from clinical trials underestimates the true extent of dropout in routine clinical care on the basis that study teams are motivated to retain participants and often provide incentives for the completion of treatment. Equally, participants may have been more inclined to drop out on the basis of the additional demands of participation in a trial, such as regular completion of research assessments. However, taking a broader approach would risk diluting higher quality sources of evidence with weaker ones. A major weakness was that reasons for dropout were not reported or were poorly reported by most studies and it was not possible to systematically extract and analyse this information.

4.3.. Research implications {#S0004-S2003}
---------------------------

Bringing together the available evidence on dropout has always been problematic given that there is no agreed definition and studies have conceptualized the phenomenon differently. Agreeing a definition of dropout would advance the field by encouraging the reporting of data that is comparable across trials. A previous study that compared the application of four operational definitions of dropout (therapist judgement, failure to attend the last scheduled appointment, a median-split procedure, and failure to return to therapy after the intake appointment) found that the rate ranged from 17.6% to 53.1%, depending on the definition that was used (Hatchett & Park, [2003](#CIT0067)). It follows that a framework to guide the standardized collection and documentation of data related to dropout including information on adverse events is needed. There is currently no theoretical concept to guide the evaluation and reporting of dropout and adverse events that occur during psychological therapy, which is needed and would include a standardized list of reasons for dropout. A first step would be for research ethics committees to mandate that future RCTs of psychological treatments routinely collect and report standardized data on dropout, including the reasons for it. When possible, studies should also report on the severity of symptoms at the point that participants drop out from therapy and whether any adverse events occurred (Hembree et al., [2003](#CIT0068)). Systematic reviews that analyse individual patient data in relation to dropout enable the application of a standardized definition across studies and would advance the field by moving beyond looking at associations between study-level variables and dropout. As noted by previous reviews, there is also a need for the standardized and consistent measurement of treatment acceptability across trials (Lewis, Roberts, Bethell, Robertson, & Bisson, [2018](#CIT0097); Simon et al., [2019](#CIT0142)). Only when we have sufficient knowledge on the reasons for dropout can we be sure that patients are receiving the best possible intervention.

4.4.. Clinical implications {#S0004-S2004}
---------------------------

Although we cannot be sure that the reasons for dropout are negative, the findings point to the need for careful assessment of the suitability of patients for trauma-focused work. Since there is evidence for the effect of many different modalities of psychological therapy (American Psychological Association, [2017](#CIT0006); International Society of Traumatic Stress Studies (ISTSS), [2018](#CIT0079); National Institute for Health and Care Excellence (NICE), [2018](#CIT0114)), a 'one-size fits all' approach should be avoided and the evidence-base used to guide shared-decision making between patient and clinician (National Institute for Health and Care Excellence (NICE), [2018](#CIT0114), Cloitre, [2015](#CIT0029)). Enhancing patient choice may improve retention on the basis that individuals are self-selecting treatment approaches that hold personal appeal. Whether or not this ultimately impacts retention and treatment outcomes requires investigation. Since PTSD is a highly heterogeneous condition (Cloitre, [2015](#CIT0029); DiMauro, Carter, Folk, & Kashdan, [2014](#CIT0039)) a greater understanding of dropout has the potential to facilitate the targeted recommendation of existing evidence-based treatments to specific sub-groups of patients. Dropout is clearly a complex phenomenon, which may be best conceptualized as having a multi-faceted aetiology that is likely to vary across different therapies and diagnostic groups. A multi-factorial approach is likely to be required to reduce dropout, such as a stepped care approach that is personalized to include stabilization if necessary and addresses the various barriers to remaining in treatment (Dorrepaal et al., [2013](#CIT0042); Zatzick, [2012](#CIT0168)). Although there is evidence to suggest that trauma-focused therapies can be safely used with a wide range of people with PTSD, including those who may be considered to have contraindications such as psychiatric comorbidities and histories of sexual abuse (Cloitre, Garvert, & Weiss, [2017](#CIT0030), van Minnen, Harned, Zoellner, & Mills, [2012](#CIT0159), Wagenmans, Van Minnen, Sleijpen, & De Jongh, [2018](#CIT0161)), further work is needed to determine any possible impact on dropout. Phased therapies have been developed with preparatory work to improve stability before trauma-focused work (Cloitre, Koenen, Cohen, & Han, [2002a](#CIT0031)). However, there is no consensus as to whether models starting with stabilization are necessary or preferable to directly applying evidence-based trauma-focused interventions (Lahuis, Scholte, Aarts, & Kleber, [2019](#CIT0094), Ter Heide, Mooren, & Kleber, [2016](#CIT0156); Ter Heide, Mooren, Kleijn, de Jongh, & Kleber, [2011](#CIT0155)). This approach has been found to result in improved outcomes and greater retention in trauma-focused CBT for PTSD (Bryant et al., [2013](#CIT0020)). Another option is the introduction of peer support, which has been shown to encourage participants to re-enter treatment and subsequently achieve significant clinical improvement (Hernandez-Tejada, Hamski, & Sánchez-Carracedo, [2017](#CIT0070)).
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[^1]: Work conducted at the Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ

[^2]: **BEP =**Brief Eclectic Psychotherapy; **NET =** Narrative Exposure Therapy

[^3]: **CBT =**Cognitive Behavioural Therapy; **OEI =**Observed and Experimental Integration

[^4]: **CBT-T =**Cognitive Behavioural Therapy with a Trauma focus; **PCT =**Present Centred Therapy

[^5]: **CPT =**Cognitive Processing Therapy; **PE =**Prolonged Exposure

[^6]: **CR =**Cognitive Restructuring; **REM Desensitization =**Rapid Eye Movement Desensitization

[^7]: **CT =**Cognitive Therapy; **RTM =**Reconsolidation of Traumatic Memories

[^8]: **DET =**Dialogical Exposure Therapy; **SC =**Supportive Counselling

[^9]: **EFT =**Emotional Freedom Technique; **TAU =**Treatment as Usual

[^10]: **EMDR** = Eye Movement Desensitization and Reprocessing**VRE =**Virtual Reality Exposure

[^11]: **I-CBT =** Internet-based Cognitive Behavioural Therapy; **WET =** Written Emotion Therapy

[^12]: **I-Psychoeducation =**Internet-based Psychoeducation; **WL =**Waiting List

[^13]: **IPT =**Interpersonal Psychotherapy

[^14]: **I-SC =**Internet-based Supportive Counselling

[^15]: **MC/RA =**Medical Checks/Repeated Assessments

[^16]: Trauma-focus coded as 0 = non-trauma focused, 1 = trauma focused; recruitment method coded as 0 = not recruited from clinical services, 1 = recruited from clinical services; delivered in a group format coded as 0 = not delivered in a group format, 1 = not delivered in a group format; sample drawn from military population coded 0 = not from a military population; 1 = from a military population; sexual trauma coded 0 = not a sexual trauma; 1 = a sexual trauma.
